As COVID-19 spreads, scientists are developing pharmaceuticals and vaccines that might treat the disease. While everyone hopes for a rapid discovery, the quest to identify therapeutics and prove their efficacy raises important ethical considerations. Furthermore, the interests of patients, the scientific community, the general public, and government officials may conflict.
This episode will outline and discuss important ethical considerations related to clinical trials, research, and treatments related to COVID-19.
Episode credits:
Content Development:Harvard Medical Student COVID-19 Curriculum
Narration: Celia Ford
Script Preparation: Celia Ford
Editing: Celia Ford
Modified with Permission from the Harvard Medical Student COVID-19 Curriculum
Original Content Authors: James Agolia, Michelle Bayefsky, Maheetha Bharadwaj, Samuel Doernberg, Melody Huang, Margaret Irwin, Bina Kassamali, Katie Kester, Benjamin Landwersiek, Sun Fletcher, Soumyaa Mazumder, Niyi Odewade, Larisa Shagabayeva, Derek Soled, Sanjana Srinivasan, Maria Thomas, Allen Zhou, Angela Zou
Original Content Editor: Derek Soled, MSc
Original Content Reviewers: Edward Hundert, MD; David S. Jones, MD, PhD; Louise King, MD, JD; Christine Mitchell, RN, MS, MTS, FAAN; Robert D. Truog, MD; David Urion, MD; Matthew Baum, PhD, DPhil; Pamela Chen; Rahul Nayak, MD; Sophia Yin
